Amylyx Pharmaceuticals Inc (AMLX) stock news · $561.6M cap
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
This AMLX news page leads with what Amylyx Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for AMLX yet. We will not pad this page with generic market recap.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AMLX stock page; for the tape open the quote page.
AMLX stock news FAQ
What is AMLX's latest net income?
Latest cached Amylyx Pharmaceuticals Inc (AMLX) net income was -$144.7M. Statements: https://lician.com/financials/amlx
What is AMLX's market cap?
Amylyx Pharmaceuticals Inc (AMLX) market cap is $561.6M on the latest cached fundamentals snapshot.
What kind of company is AMLX?
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Where is AMLX stock news listed?
Cached stock news for Amylyx Pharmaceuticals Inc (AMLX) is listed at https://lician.com/news/amlx. Filings: https://lician.com/sec/amlx
Not investment advice.